News
Risk of progression differs in high risk and low risk cases when surgery is omitted Ductal carcinoma in situ (DCIS) is a non-obligate precursor lesion of invasive breast cancer. Since the ...
Cancer is the greatest cause of mortality in the world wherein; Breast Invasive Ductal Carcinoma (IDC) is the second leading cause of death among women. Computer-assisted diagnostic (CAD) systems ...
Researchers are hoping to find new ways to predict when an early form of breast cancer is likely to progress and develop new treatments for those at risk, thanks to new funding from Breast Cancer Now.
As a teen, 'Inside Edition' correspondent Alison Hall hated her small breasts. Cancer took them from her at age 32, and she ...
Langley Perer, a beloved Hollywood manager and producer, died June 25, 2025 following a four-year battle with cancer. She was ...
10d
MedPage Today on MSNFor Your Patients: What to Know About Breast Cancer HER2 StatusHER2 tumor marker tests are used to determine whether breast cancer is HER2 positive or negative. A person is a candidate for ...
A West Lothian woman who received a breast cancer diagnosis out of the blue is taking on a marathon-length moonlit challenge.
About 316,950 new cases of invasive breast cancer will be diagnosed in women. About 59,080 new cases of ductal carcinoma in situ (DCIS) will be diagnosed. About 42,170 women will die from breast ...
12d
healthdigest.com on MSNWhat It Means When Cancer Is 'In Situ' And Why It's The Most CurableHave you ever heard about a cancer that is "in situ"? There's a reason why it's called that -- and why it's the kind of ...
The Helsinki-based firm's test is used to automate breast cancer grading using AI-developed models, and it is integrated into the firm's breast cancer suite.
Singer Jessie J. recently shared her breast cancer journey, highlighting the importance of early detection. Breast cancer, a disease where breast cell ...
Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results